Teva overnights generic EpiPen to pharmacies amid shortage

Teva Pharmaceuticals reports that it is shipping its generic version of the epinephrine auto-injector (EpiPen—Mylan) to U.S. pharmacies in short supply in 24 hours. "I think it's fair to say that we feel that we are filling a gap in the marketplace because it feels like it's very strong demand," said CEO Kare Schultz.

Teva Pharmaceuticals reports that it is shipping its generic version of the epinephrine auto-injector (EpiPen—Mylan) to U.S. pharmacies in short supply in 24 hours. "I think it's fair to say that we feel that we are filling a gap in the marketplace because it feels like it's very strong demand," said CEO Kare Schultz. While increased demand has led to a shortage of Mylan's brand-name EpiPen product, Schultz said Teva is "able to fulfill any requests.